These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20126975)

  • 1. TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer.
    Miyoshi N; Ishii H; Mimori K; Sekimoto M; Doki Y; Mori M
    Int J Oncol; 2010 Mar; 36(3):563-8. PubMed ID: 20126975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1.
    Hamada S; Watanabe K; Hirota M; Bianco C; Strizzi L; Mancino M; Gonzales M; Salomon DS
    Biochem Biophys Res Commun; 2007 Mar; 355(1):240-4. PubMed ID: 17291450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.
    Nakagawa S; Miyoshi N; Ishii H; Mimori K; Tanaka F; Sekimoto M; Doki Y; Mori M
    Int J Oncol; 2011 Oct; 39(4):791-6. PubMed ID: 21720707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto as a target for cancer immunotherapy.
    Hu XF; Xing PX
    Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and biological significance of cripto overexpression in human colon cancer.
    Jiang PC; Zhu L; Fan Y; Zhao HL
    World J Gastroenterol; 2013 Dec; 19(46):8630-7. PubMed ID: 24379580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCRN1 is a novel marker for prognosis in colorectal cancer.
    Miyoshi N; Ishii H; Mimori K; Sekimoto M; Doki Y; Mori M
    J Surg Oncol; 2010 Feb; 101(2):156-9. PubMed ID: 20039278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratocarcinoma-derived growth factor 1 (TDGF1) sequence variants in patients with congenital heart defect.
    Wang B; Yan J; Peng Z; Wang J; Liu S; Xie X; Ma X
    Int J Cardiol; 2011 Jan; 146(2):225-7. PubMed ID: 19853938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer.
    Sato J; Karasawa H; Suzuki T; Nakayama S; Katagiri M; Maeda S; Ohnuma S; Motoi F; Naitoh T; Unno M
    Cancer Invest; 2020 Apr; 38(4):214-227. PubMed ID: 32157913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.
    Miyoshi N; Ishii H; Mimori K; Takatsuno Y; Kim H; Hirose H; Sekimoto M; Doki Y; Mori M
    Br J Cancer; 2009 Nov; 101(10):1664-70. PubMed ID: 19904274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
    Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
    Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1: an embryonic gene that promotes tumorigenesis.
    de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
    Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes.
    Liguori G; Tucci M; Montuori N; Dono R; Lago CT; Pacifico F; Armenante F; Persico MG
    Mamm Genome; 1996 May; 7(5):344-8. PubMed ID: 8661720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
    Bianco C; Normanno N; Salomon DS; Ciardiello F
    Growth Factors; 2004 Sep; 22(3):133-9. PubMed ID: 15518236
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects.
    de la Cruz JM; Bamford RN; Burdine RD; Roessler E; Barkovich AJ; Donnai D; Schier AF; Muenke M
    Hum Genet; 2002 May; 110(5):422-8. PubMed ID: 12073012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.